Dobutamine stress myocardial perfusion imaging: 8-year outcomes in patients with diabetes mellitus
Conclusion
In high-risk patients with diabetes mellitus, dobutamine MPI provides incremental prognostic information in addition to clinical data for a 4-year period after testing.
Source: European Journal of Echocardiography - Category: Cardiology Authors: Boiten, H. J., van Domburg, R. T., Valkema, R., Zijlstra, F., Schinkel, A. F. L. Tags: ORIGINAL ARTICLES Source Type: research
More News: Cardiology | CT Scan | Diabetes | Diabetes Mellitus | Endocrinology | Heart Attack | Perfusion | SPECT | Sports Medicine | Study